Bartosz Hudzik: New Evidence on “Aspirin Failure” After Ischemic Stroke
Bartosz Hudzik, Editorial Consultant at JACC Case Reports, shared on LinkedIn:
”New evidence on “aspirin failure” after ischemic stroke
Patients who suffer an ischemic stroke while already taking aspirin represent a high-risk and frustrating clinical group.
The common reflex is to switch antithrombotic therapy—but does it actually help?
A new systematic review and network meta-analysis of 9 randomized trials (5,459 patients, median follow-up ~19 months) found:
- Switching to another antithrombotic (DOAC, DAPT, or warfarin) did not significantly reduce recurrent ischemic stroke compared with continuing aspirin
- No significant benefit was seen for the composite outcome of stroke, MI, or death
- DOACs (dabigatran, apixaban) and aspirin plus low-dose rivaroxaban ranked highest in network analyses—but none were superior to aspirin
Bottom line: After an ischemic stroke on aspirin, simply switching antithrombotic therapy may not meaningfully improve outcomes.
This highlights a major unmet need—and the importance of trials designed specifically for this growing population.
Read the full article here.”
Article: Switching From Aspirin Monotherapy After Noncardioembolic Stroke: A Systematic Review and Network Meta-Analysis
Authors: Aaron Rothstein, Ossama Khazaal, Steven Messe, Yulun Liu, Sean Hennessy, Yong Chen, Ale Algra, Shinichiro Uchiyama, Sven Poli, Tobias Geisler, Lina Maria Serna Higuita, Kanjana Perera, Amanda Taylor, Scott E. Kasner
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 10, 2026, 02:38Brianne D.: Sex Differences in RIPK1 Signaling Following Intracerebral Hemorrhage
-
Oct 10, 2026, 02:17Dino Mehic: Managing Heavy Menstrual Bleeding in Patients with BDUC
-
Oct 10, 2026, 00:34Raphaëlle Dodart: Discussing the Mechanisms of Menstrual Hemostasis
-
Oct 10, 2026, 00:26Barbara Adams Krolak: Discussing the Growing Need for Blood Clot Prevention in Asia
-
Oct 9, 2026, 23:59Ana Pedrero Gil: Is Coagulopathy with Fibrinolysis Present in All Obstetric Hemorrhages?
-
Oct 9, 2026, 23:57Exploring the Psychosocial Needs of People with Bleeding Disorders in Kyrgyzstan – EAHAD
-
Oct 9, 2026, 23:53Bernard Slater Jr.: Serving on the Advisory Council for the NBDF West Virginia Chapter
-
Oct 9, 2026, 23:53Aurelio Maggio: Thalassemia Reports Real-Time Impact Factor Rises to 1.760
-
Oct 9, 2026, 23:52Stronger Connections, Stronger Organizations – World Federation of Hemophilia